Orca-T with reduced-intensity stem cell transplantation was a safe, feasible alternative to conventional transplant in blood ...

Referral to an infectious disease physician was the only modifiable strategy to reduce 28-day mortality among adults presenting to the ED with bacteremia.

Sanofi SA (NASDAQ:SNY) and Johnson & Johnson (NYSE:JNJ) have discontinued the E.mbrace phase 3 study evaluating a vaccine ...

improves 30-day clinical outcomes in patients hospitalized with Enterobacterales bacteremia. “Starting early PDAT may be important not only for antimicrobial stewardship but also for improving ...

Fog is a common, natural occurrence that has a variety of possible sources. Most often in Florida, it happens when either warm energy from the ground radiates into space on a clear night, cooling the ...

Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study Independent interim analysis of the E.mbrace phase 3 study finds that the vaccine candidate didn’t demonstrate sufficient ...

Sanofi and Johnson & Johnson’s E. coli vaccine candidate failed to prevent invasive E. coli disease effectively.

A scheduled review of the E.mbrace phase 3 study (clinical trial identifier: NCT04899336) conducted by an independent data monitoring committee (IDMC) determined that Sanofi and Johnson & Johnson’s ...

Febrile infants aged 22 to 60 days were less likely to be hospitalized or receive antibiotics after the AAP published updated ...

While children under five, particularly those under two, are the most vulnerable, pneumococcal diseases also affect adults. The most common symptoms include cough, chills and fever.

The value of humility is learned through experience: “You have to be humble enough to know that you will make errors in ...